{"id":"NCT02422615","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.","officialTitle":"A Randomized Double-blind, Placebo-controlled Study of Ribociclib in Combination With Fulvestrant for the Treatment of Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Who Have Received no or Only One Line of Prior Endocrine Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-09","primaryCompletion":"2017-11-03","completion":"2023-01-11","firstPosted":"2015-04-21","resultsPosted":"2018-09-19","lastUpdate":"2023-11-30"},"enrollment":726,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Advanced Breast Cancer"],"interventions":[{"type":"DRUG","name":"Ribociclib","otherNames":["LEE011"]},{"type":"DRUG","name":"Fulvestrant","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ribociclib + fulvestrant","type":"EXPERIMENTAL"},{"label":"Placebo + fulvestrant","type":"PLACEBO_COMPARATOR"}],"summary":"The main aim of this study was to evaluate the efficacy and safety of adding ribociclib to fulvestrant in men and postmenopausal women with hormone receptor positive (HR+), HER2-negative advanced breast cancer.","primaryOutcome":{"measure":"Progression Free Survival (PFS) Per Investigator Assessment","timeFrame":"From randomization to first documented progression or death, assessed up to approximately 26 months","effectByArm":[{"arm":"Ribociclib + Fulvestrant","deltaMin":20.5,"sd":null},{"arm":"Placebo + Fulvestrant","deltaMin":12.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.00000041"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":4},"locations":{"siteCount":174,"countries":["United States","Australia","Austria","Belgium","Bulgaria","Canada","Colombia","Czechia","Denmark","France","Germany","Hungary","Italy","Jordan","Lebanon","Malaysia","Mexico","Netherlands","Norway","Poland","Portugal","Russia","Singapore","South Korea","Spain","Sweden","Switzerland","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["39826197","37673211","37653397","36800111","34158598","34102253","33769862","31826360","31305131","29860922"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":179,"n":483},"commonTop":["Nausea","Neutropenia","Fatigue","Arthralgia","Diarrhoea"]}}